Literature DB >> 28202699

Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA.

Yuesong Pan1, Xia Meng1, Jing Jing1, Hao Li1, Xingquan Zhao1, Liping Liu1, David Wang1, S Claiborne Johnston1, Yilong Wang2, Yongjun Wang.   

Abstract

OBJECTIVE: To estimate the association of different patterns of infarction and intracranial arterial stenosis (ICAS) with the prognosis of acute minor ischemic stroke and TIA.
METHODS: We derived data from the Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) trial. A total of 1,089 patients from 45 of 114 participating sites of the trial undergoing baseline MRI/angiography were included in this subgroup analysis. Patterns of infarction and ICAS were recorded for each individual. The primary efficacy outcome was an ischemic stroke at the 90-day follow-up. We assessed the associations between imaging patterns and prognosis of patients using multivariable Cox regression models.
RESULTS: Among the 1,089 patients included in this subgroup analysis, 93 (8.5%) patients had a recurrent ischemic stroke at 90 days. Compared with those without infarction or ICAS, patients with single infarction with ICAS (11.9% vs 1.3%, hazard ratio [HR] 6.25, 95% confidence intervals [CIs] 1.40-27.86, p = 0.02) and single infarction without ICAS (6.8% vs 1.3%, HR 4.65, 95% CI 1.05-20.64, p = 0.04) were all associated with an increased risk of ischemic stroke at 90 days. Patients with both multiple infarctions and ICAS were associated with approximately 13-fold risk of ischemic stroke at 90 days (18.0% vs 1.3%, HR 13.14, 95% CI 2.96-58.36, p < 0.001).
CONCLUSIONS: The presence of multiple infarctions and ICAS were both associated with an increased risk of 90-day ischemic stroke in patients with minor stroke or TIA, while the presence of both imaging features had a combined effect. CLINICALTRIALSGOV IDENTIFIER: NCT00979589.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28202699     DOI: 10.1212/WNL.0000000000003719

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28

2.  Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.

Authors:  Jing Jing; Xia Meng; Xingquan Zhao; Liping Liu; Anxin Wang; Yuesong Pan; Hao Li; David Wang; S Claiborne Johnston; Yongjun Wang; Yilong Wang
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

3.  Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes.

Authors:  Huimin Chen; Yuesong Pan; Lixia Zong; Jing Jing; Xia Meng; Yuyuan Xu; Hongyi Yan; Xingquan Zhao; Liping Liu; Hao Li; S Claiborne Johnston; Yongjun Wang; Yilong Wang
Journal:  Stroke Vasc Neurol       Date:  2020-04-15

4.  The Impact of Cerebral Microbleeds Presence on Outcome Following Minor Stroke Treated With Antiplatelet Therapy.

Authors:  Kenichi Sakuta; Hiroshi Yaguchi; Takeo Sato; Teppei Komatsu; Kenichiro Sakai; Hidetaka Mitsumura; Satoshi Matsushima; Yasuyuki Iguchi
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

5.  The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics.

Authors:  Yongjun Wang; Jing Jing; Xia Meng; Yuesong Pan; Yilong Wang; Xingquan Zhao; Jinxi Lin; Wei Li; Yong Jiang; Zixiao Li; Xinmiao Zhang; Xiaomeng Yang; Ruijun Ji; Chunjuan Wang; Zhimin Wang; Xinsheng Han; Songdi Wu; Zhengchang Jia; Yongming Chen; Hao Li
Journal:  Stroke Vasc Neurol       Date:  2019-06-29

6.  Fasting glucose and HbA1c levels as risk factors for the presence of intracranial atherosclerotic stenosis.

Authors:  Yan-Li Wang; Xin-Yi Leng; Yi Dong; Xiao-He Hou; Lin Tong; Ya-Hui Ma; Wei Xu; Mei Cui; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.